Divis Laboratories Ltd | DIVI - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Alaunos Therapeutics USD 1.01M 175K 2026-03
Aurobindo Pharma INR 77.12B 1.81B 2026-06
Avita Medical AUD 28.02M 1.55M 2025-12
Dianthus Therapeutics USD 47M 22.83M 2026-03
Divis Laboratories Ltd INR 19.51B 660M 2026-06
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
IQVIA Holdings USD 3.82B 2.05B 2026-09
Lupin INR 62.66B 5.99B 2026-06
Moderna USD 960M 817M 2026-06
Organon & Co USD 1.01B 103M 2026-06
Revvity USD 603.55M 24.8M 2026-06
Tectonic Therapeutic USD 27.3M 5.78M 2026-03
Tilray USD 237.52M 17.34M 2025-09
Viatris USD 3.68B 145.9M 2026-06
Xeris Pharmaceuticals USD 75.21M 6.18M 2026-03